This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: D.e. Shaw Research, LLC, Relay Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Innovator Spotlight: Hanmo Zhang
Introduction
Hanmo Zhang is an influential inventor based in Cambridge, MA, recognized for his contributions to the field of pharmaceutical sciences. With a focus on targeted therapies, he has made significant advancements that hold promise for treating disorders related to PI3K-α signaling.
Latest Patents
Zhang holds a noteworthy patent titled "Substituted isoindolines as PI3K-alpha inhibitors." This patent relates to novel compounds and pharmaceutical compositions aimed at inhibiting the activity of PI3K-α enzymes. The implications of his work extend to methods of treating disorders associated with PI3K-α signaling, showcasing the potential for innovative therapies derived from his research.
Career Highlights
Throughout his career, Hanmo Zhang has garnered valuable experience working for prominent companies such as Relay Therapeutics, Inc. and D.E. Shaw Research, LLC. His strategic roles at these organizations have facilitated his growth as a leading figure in the field, allowing him to contribute to various innovative projects.
Collaborations
Zhang has also collaborated with talented individuals in the industry, including his coworker Lucian V Dipietro. Such collaborations often enhance the creativity and effectiveness of research initiatives, ultimately driving forward the development of groundbreaking solutions.
Conclusion
Hanmo Zhang's innovative spirit and dedication to advancing pharmaceutical sciences are evident through his patent and professional endeavors. His work has the potential to positively impact the treatment landscape for disorders influenced by PI3K-α signaling, marking him as an inventor to watch in the years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile